Results 221 to 230 of about 62,748 (289)

Noradrenergic Slow Vasomotion: The Hidden Fluid Pump Linking Sleep, Brain Clearance, and Dementia Pathogenesis. [PDF]

Int J Mol Sci
Dabija MG, Tataru CI, Dumitru AV, Munteanu O, Radoi MP, Ciurea AV, Petrescu IA.   +6 more
europepmc   +1 more source

Real-World Vortioxetine Prescription for Patients With Major Depressive Disorder in Japan: A Retrospective Cohort Study Using a Japanese Health Insurance Claims Database. [PDF]

Neuropsychopharmacol Rep
Kato M, Hoshino T, Kawata Y, Tokuda F, Fujimoto S.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Noradrenergic Function in Suicide

Archives of Suicide Research, 2007
Although abnormalities in serotonergic function have been the major focus of studies on suicidal behavior, several studies indicate that abnormalities of noradrenergic function may also be involved in the pathophysiology of suicide. In this paper, we have reviewed some of the noradrenergic studies in suicide, including studies of the biosynthetic ...
Ghanshyam N, Pandey, Yogesh, Dwivedi
openaire   +2 more sources

Sex and the noradrenergic system

2020
The central noradrenergic system comprises multiple brainstem nuclei whose cells synthesize and release the catecholamine transmitter norepinephrine (NE). The largest of these nuclei is the pontine locus coeruleus (LC), which innervates the vast majority of the forebrain.
Neal, Joshi, Daniel, Chandler
openaire   +2 more sources

Noradrenergic modulation of lymphohematopoiesis

International Journal of Immunopharmacology, 1994
Adrenergic agents can affect hematopoiesis after syngeneic bone marrow transplantation (BMT) in mice. In particular, chemical sympathectomy by 6-hydroxydopamine and/or administration of various doses of the alpha 1-adrenergic antagonist prazosin were shown to increase the concentration of blood granulocytes, platelets and bone marrow granulocyte ...
G J, Maestroni, A, Conti
openaire   +2 more sources

Noradrenergic Function in Schizophrenia

Archives of General Psychiatry, 1987
Yohimbine, an alpha 2-adrenergic receptor antagonist that increases noradrenergic function, was administered to 16 healthy subjects and 18 drug-free schizophrenic patients with (n = 10) and without (n = 8) tardive dyskinesia (TD). Outcome measures of this double-blind, placebo-controlled study included changes in behavior, plasma 3-methoxy-4-hydroxy ...
W M, Glazer, D S, Charney, G R, Heninger
openaire   +2 more sources